Skip to main content
logo
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
12.63
-1.14 (-8.28%)
Sep 1, 2026, 4:00 PM EDT - Market closed

Kazia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
144772658128
Market Cap Growth
1499.82%2.91%-74.25%-54.61%-54.40%298.54%
Enterprise Value
98552447113
Last Close Price
12.636.2711.4358.00210.00493.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
113.965.854.1139743.178458.3411.23
PB Ratio
4.62-1.29-1.023.304.634.50
P/TBV Ratio
4.77----10.76

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
77.434.342.8035823.576855.409.91

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.00-0.05-0.060.150.10-
Net Debt / Equity Ratio
-1.490.480.10-0.29-0.30-0.73
Net Debt / EBITDA Ratio
3.890.300.040.160.245.40
Net Debt / FCF Ratio
4.820.300.110.230.243.03
Asset Turnover
0.040.130.10000.37
Quick Ratio
2.860.320.070.711.103.32
Current Ratio
2.870.350.241.421.403.53
Return on Equity (ROE)
-106.90%--2634.33%-134.97%-89.14%-32.41%
Return on Assets (ROA)
-25.70%-64.28%-71.63%-47.18%-33.76%-9.83%
Return on Capital Employed (ROCE)
-39.20%177.90%675.70%-117.70%-87.00%-12.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-10.54%-193.64%-262.32%-51.49%-29.57%-4.94%
FCF Yield
-7.11%-124.20%-93.86%-38.14%-26.91%-5.34%
Buyback Yield / Dilution
-213.01%-107.81%-43.08%-39.12%-12.57%-61.08%
SEC Filings: 10-K · 10-Q